WOCKHARDT
|
The Current P/B Ratio of WOCKHARDT is 4.86.
| Share Price | ₹1,299.0 | Mar 06,2026 |
| Market Cap | ₹21,107.9 Cr | |
| Book Value | ₹4,341.0 Cr | Mar2025 - Consolidated Results |
| Price/Book | 4.86x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of WOCKHARDT
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹21,107.9 Cr] as on Mar 06,2026
(/) Book Value [ ₹4,341.0 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 4.86x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '4.86 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WOCKHARDT !
The chart below summarizes the trend in P/B Ratio of WOCKHARDT over the last five years.
Historical PB (Price/Book ) ratio chart of WOCKHARDT
PB Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.20x.
- WOCKHARDT 's operated at median p/b ratio of 1.36x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/b ratio peaked in Mar2025 at 5.31x.
- WOCKHARDT 's p/b ratio hit its five-year low in Mar2023 of 0.66x.
How does WOCKHARDT 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| WOCKHARDT | 4,341.00 | 4.86 | 21,107.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.98 | 431,628.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.22 | 167,975.0 |
| CIPLA LTD | 31,079.30 | 3.44 | 106,768.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 19.21 | 145,804.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.26 | 108,829.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.32 | 90,257.8 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.84 | 91,864.1 |
| LUPIN LTD | 17,119.50 | 6.26 | 107,152.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.19 | 71,531.5 |
| ABBOTT INDIA LTD | 4,204.27 | 13.82 | 58,106.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WOCKHARDT 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.19x |
| Max industry PB | 19.21x |
| Median industry PB | 5.98x |
| Average industry PB | 7.31x |
You may also like the below Video Courses